DSHEA

NION Health™ Launches Breakthrough Electrolyte Supplement, Moving Negative Ions into Positive Spotlight

Retrieved on: 
Wednesday, April 19, 2023
Electrolyte, Exercise, Edible, Food, University, Health, NION, Noetics, DSHEA, Laboratory, University of Washington Department of Global Health, Water, Coffee, FDA, Fasting, NDI, Pharmaceutical industry, Electric battery, Dietary supplement

EVERETT, Wash., April 19, 2023 /PRNewswire/ -- NION Health, a division of Galahad Life Sciences, today announces the launch of its electrolyte supplement, NION™ Electrolyte Drink Mix, that safely and effectively delivers meaningful doses of negative ions to improve hydration, replenish lost minerals, increase stamina, detoxify, and amplify the regenerative effects of intermittent fasting. The product is now available at nionhealth.com in 30-day packs for $68. Through double blind clinical trials, consumption of NION for one week improved participants' hydration, stamina, recovery and mitochondrial function.

Key Points: 
  • Through double blind clinical trials, consumption of NION for one week improved participants' hydration, stamina, recovery and mitochondrial function.
  • "Our bodies need a balance of both positive and negative ions to support cell function, and that's where NION comes in," says Steve Loyd, CEO Galahad Life Sciences.
  • This supports increased hydration, water balance, replacement of lost positive and negative ions from fasting, greater stamina during exercise and more.
  • Pure Branding is the brand strategy, market research and brand activation agency guiding NION Health through inception, creation and launch.

Doctor's Best Joins Forces with the Council for Responsible Nutrition and the United Natural Products Alliance

Retrieved on: 
Monday, April 17, 2023
Sprouts, Council for Responsible Nutrition, Food, Freedom, Health, Marketing, Dietary Supplement Health and Education Act of 1994, Functional food, CRN, Best, DSHEA, Science, Amazon, Good manufacturing practice, Walmart, Dietary supplement, CGMP, Council, UNPA, Quality control, Safety, Nursing, Ethics

TUSTIN, Calif., April 17, 2023 /PRNewswire/ -- Doctor's Best Inc., a leading nutritional supplements company, announced today a membership affiliation with two major industry associations, the Council for Responsible Nutrition (CRN) and the United Natural Products Alliance (UNPA). The new memberships reinforce Doctor's Best's ongoing initiatives, geared toward empowering consumers with access to high-quality supplements and science-based information.

Key Points: 
  • TUSTIN, Calif., April 17, 2023 /PRNewswire/ -- Doctor's Best Inc., a leading nutritional supplements company, announced today a membership affiliation with two major industry associations, the Council for Responsible Nutrition (CRN) and the United Natural Products Alliance (UNPA).
  • The alliance continues to take a leadership position in state and federal legislative and regulatory issues and industry best practices.
  • All of Doctor's Best products are manufactured and rigorously tested exclusively at Current Good Manufacturing Practice (cGMP) certified facilities in the United States.
  • The United Natural Products Alliance (UNPA) is an international trade association representing nearly 100 leading natural products, dietary supplement, functional food, scientific and technology and related service companies that share a commitment to provide consumers with natural health products of superior quality, benefit and reliability.

NextEvo, Inc. Taps Coral Reef Labs on CBD Study: Most Brands 50% Off Label Claims

Retrieved on: 
Monday, March 27, 2023
Wing, DSHEA, Gallup, Dietary supplement, Quality control, Cannabidiol, Pharmaceutical industry, South Central Pennsylvania, CBD

CONSHOHOCKEN, PA, March 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- NextEvo Naturals (“NextEvo™” or the “Company”), a premium supplement brand focused on revolutionizing the delivery of nutritional compounds, announced today results from a third-party study on 16 randomly selected cannabidiol (CBD) products that were purchased from large chain retailers in Pennsylvania locations and online, which showed large inconsistencies with label claims.

Key Points: 
  • Coral Reef Labs performs comprehensive analytical testing from its state approved laboratory in Central Pennsylvania.
  • Among the products tested were large national brands such as Charlotte's Web, SocialCBD, CV Sciences, and retailers’ own brands, along with emerging brands such as Winged and CBDistillery.
  • “We are proud to participate in a study that allowed us to offer an unbiased, third-party analysis of current, trending CBD products on the market,” said Lou McCloskey, General Manager of Coral Reef Labs.
  • This study’s results show the clear need for further regulation and oversight over the CBD category and the need for transparency from brands.

STEMTECH CORPORATION ANNOUNCES LIFE FACTOR RESEARCH BECOMES PART OF STEMTECH

Retrieved on: 
Tuesday, October 25, 2022
Time, Longevity, Growth, Policy, Report, Stem cell, EMF, Acquisition, Bone marrow, GLOBE, CGMP, B cell, Private Securities Litigation Reform Act, DSHEA, Family, Adult, Company, Government, Dietary Supplement Health and Education Act of 1994, Research, LFR, CEO, Dentistry, Health, Patent, Leadership, Security (finance), Pharmaceutical industry

Stemtech Corporation President and Chief Operating Officer, John W. Meyer, said we are extremely pleased to announce the finalization of the agreement to add Life Factor Research to the family of Stemtech Corporation businesses as the division responsible for research and development and product formulations.

Key Points: 
  • Stemtech Corporation President and Chief Operating Officer, John W. Meyer, said we are extremely pleased to announce the finalization of the agreement to add Life Factor Research to the family of Stemtech Corporation businesses as the division responsible for research and development and product formulations.
  • This new arrangement will enable Stemtech to offer more new, cutting-edge products to an ever-growing market interested in improved health and quality of life.
  • We will be developing many new products in close consultation with Life Factor Research for improving health benefits, anti-aging and longevity around the globe.
  • Charles Layton, CEO of Life Factor Research commented that from our beginnings, Life Factor Research has held fast to our foundational concept of creating nutraceutical products that through their proprietary nature and scientific proof create lasting change for our clients and their customers.

STEMTECH CORPORATION ANNOUNCES NEW BOARD OF DIRECTORS FOR STEMTECH MALAYSIA SDN. BHD.

Retrieved on: 
Thursday, October 13, 2022
BHD, Time, Government, Dietary Supplement Health and Education Act of 1994, B cell, Policy, CGMP, COO, Security (finance), Bone marrow, Private Securities Litigation Reform Act, Report, EMF, Business, Company, DSHEA, Board, CEO, Patent, Adult, GLOBE, Board of directors, Director, Dentistry, Leadership, Management

Stemtech Corporation President and Chief Operating Officer, John W. Meyer, said Stemtech Malaysia has made changes to the Board of Directors.

Key Points: 
  • Stemtech Corporation President and Chief Operating Officer, John W. Meyer, said Stemtech Malaysia has made changes to the Board of Directors.
  • In addition to current local Director, Mr. Shukor, Charles S Arnold, CEO Stemtech Corporation, David E. Price, Stemtech Corporation Counsel, also became directors.
  • Charles S. Arnold, Stemtech Corporation Chairman and CEO elaborated that as part of the new board, John W. Meyer, President & COO of Stemtech Corporation was elected to serve as Chairman of the Stemtech Malaysia Board of Directors.
  • Together we reaffirm that Stemtech Corporation believes in the market opportunities which Malaysia represents, assuring our commitment to our Independent Business Partners.

STEMTECH CORPORATION INVITED TO PRESENT AT ROTH CAPITAL HEALTHCARE OPPORTUNITIES CONFERENCE IN NEW YORK CITY

Retrieved on: 
Tuesday, October 4, 2022
B cell, GLOBE, Government, Dietary Supplement Health and Education Act of 1994, Adult, Time, Private Securities Litigation Reform Act, Dentistry, Health, Patent, CGMP, Roth Capital Partners, Longevity, DSHEA, Policy, Bone marrow, Leadership, Security (finance), Conference, Report, EMF, Company, Pharmaceutical industry, Biotechnology

MIRAMAR, FL, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (Stemtech) (OTCQB: STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, today that it was invited to present at the Roth Capital Healthcare Opportunities Conference in New York City on October 6.

Key Points: 
  • MIRAMAR, FL, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (Stemtech) (OTCQB: STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, today that it was invited to present at the Roth Capital Healthcare Opportunities Conference in New York City on October 6.
  • Stemtech Corporation CEO Charles S. Arnold says that it is an honor for Stemtech to be invited to present at such a prestigious forum as the Roth Capital Partners event.
  • Stemtech Corporation, a leading nutraceutical company with a direct sales distribution model, was founded on April 18, 2018, after acquiring the operations from its predecessor Stemtech International, Inc. which was founded in 2005.
  • From 2010 through 2015, Stemtech International, Inc., was recognized four separate times on the Inc. 5000 Fastest-Growing Companies list.

STEMTECH CORPORATION ANNOUNCES THE INTRODUCTION OF A NEW STEM CELL SKINCARE PRODUCT LINE

Retrieved on: 
Monday, September 19, 2022
Adult, Time, Policy, CGMP, Company, Growth, Dentistry, Business, Government, Institute of Banking Personnel Selection, EMF, CEO, Dietary Supplement Health and Education Act of 1994, Bone marrow, B cell, Report, Leadership, Private Securities Litigation Reform Act, Science, CAGR, Security (finance), GLOBE, RCM, Skin, Skin care, Patent, DSHEA, Cosmetics, Pharmaceutical industry

MIRAMAR, FL, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (Stemtech) (OTCQB: STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, today announced creation of new stem cell skincare products.

Key Points: 
  • MIRAMAR, FL, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (Stemtech) (OTCQB: STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, today announced creation of new stem cell skincare products.
  • Stemtech Corporation President and Chief Operating Officer, John W. Meyer, said the introduction of the stem cell skincare line is very exciting for us to offer our Independent Business Partners (IBPs) and customers.
  • Charles S. Arnold, Stemtech Corporation Chairman and CEO stated that the introduction of skincare focuses new Stemtech stem cell technology on skincare for healthier skin, the largest organ of the body, which we recognize as a key to anti-aging.
  • We know our IBPs will be exuberant with this great new Stemtech Skincare product line.

STEMTECH CORPORATION ANNOUNCES GO LIVE OF STEMTECH ADVANCE OFFICE BASED ON VERB TECHNOLOGY MONDAY SEP 19!

Retrieved on: 
Wednesday, September 14, 2022
Adult, Time, Policy, VERB, CGMP, Company, Dentistry, Partnership, Government, Institute of Banking Personnel Selection, EMF, Dietary Supplement Health and Education Act of 1994, Business, Bone marrow, B cell, Nasdaq, Report, Leadership, Private Securities Litigation Reform Act, NASDAQ, Security (finance), GLOBE, Software as a service, Communication, Patent, DSHEA

MIRAMAR, FL, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (Stemtech) (OTCQB: STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, today announced the Go-Live date of their Stemtech Advance Office based on the VERB Technology Company, Inc. (NASDAQ: VERB) system.

Key Points: 
  • MIRAMAR, FL, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (Stemtech) (OTCQB: STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, today announced the Go-Live date of their Stemtech Advance Office based on the VERB Technology Company, Inc. (NASDAQ: VERB) system.
  • We are proud to have this partnership with VERB, who provide Stemtech with direct sales recruiting, retention and expansion of business capabilities.
  • This partnership with such a prominent provider is an exciting step and will help drive momentum for Stemtech.
  • Verb Technology Company, Inc. (Nasdaq: VERB), the market leader in interactive video-based sales applications, transforms how businesses attract and engage customers.

Stemtech Corporation Announces Go Live of Stemtech Advance Office Based on VERB Technology Monday Sep 19

Retrieved on: 
Wednesday, September 14, 2022
Adult, Time, Policy, VERB, CGMP, Company, Dentistry, Partnership, Government, Institute of Banking Personnel Selection, EMF, Dietary Supplement Health and Education Act of 1994, Business, Bone marrow, B cell, Nasdaq, Report, Leadership, Private Securities Litigation Reform Act, NASDAQ, Security (finance), GLOBE, Software as a service, Communication, Patent, DSHEA

MIRAMAR, Fla., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (Stemtech) (OTCQB: STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, today announced the Go-Live date of their Stemtech Advance Office based on the VERB Technology Company, Inc. (NASDAQ: VERB) system.

Key Points: 
  • MIRAMAR, Fla., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (Stemtech) (OTCQB: STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, today announced the Go-Live date of their Stemtech Advance Office based on the VERB Technology Company, Inc. (NASDAQ: VERB) system.
  • Stemtech Corporation President and Chief Operating Officer, John W. Meyer, said we are extremely happy to announce go-live for Monday, September 19, 2022.
  • We are proud to have this partnership with VERB, who provide Stemtech with direct sales recruiting, retention and expansion of business capabilities.
  • Verb Technology Company, Inc. (Nasdaq: VERB), the market leader in interactive video-based sales applications, transforms how businesses attract and engage customers.

STEMTECH CORPORATION ANNOUNCES PROFESSOR DR. BANKOLE JOHNSON JOINS THEIR LIFE SCIENCES ADVISORY BOARD

Retrieved on: 
Tuesday, September 6, 2022
COVID-19, CEO, Life, Academy, Professor, CASA, Dietary Supplement Health and Education Act of 1994, Science, CNN, Report, Anatomy, GLOBE, Medicine, Leadership, Company, Founder, Adult, HBO, Biomedical sciences, EMF, Government, Time, Lists of diseases, Master's degree, Addiction, 48th Daytime Emmy Awards, Department, CGMP, DSHEA, Psychiatry, Pharmacology, Dentistry, Forbes, Larkin University, Security (finance), NASDAQ, Psychopharmacology, Patent, MD, Alumnus, B cell, Private Securities Litigation Reform Act, Health, University, Television, Neuroscience, Policy, University of Virginia, Education, History of the University of Maryland, College Park, Bone marrow, Pharmaceutical industry, Management

MIRAMAR, FL, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (Stemtech) (OTCQB: STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, today announced that Professor Dr. Bankole Johnson joins the Stemtech Corporation Life Sciences Advisory Board (LSAB).

Key Points: 
  • MIRAMAR, FL, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (Stemtech) (OTCQB: STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, today announced that Professor Dr. Bankole Johnson joins the Stemtech Corporation Life Sciences Advisory Board (LSAB).
  • Stemtech Corporation President and Chief Operating Officer, John W. Meyer, said Professor Dr. Bankole Johnson joining Stemtechs Life Sciences Advisory Board is a great addition to our Team.
  • Charles S. Arnold, Stemtech Corporation Chairman and CEO stated that with the addition of Professor Dr. Bankole Johnson, Stemtech continues to make forward strides toward our strategic goal of providing leading-edge and advanced products for health and wellness.
  • Professor Dr. Johnson also functions as a Professor of Biomedical Sciences at Larkin University in Miami.